SCHEMBL5236887

SCHEMBL5236887

O=C(Cc1ccnc2ccccc12)c1cccc(Br)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.43
TGFBR1 P36897 1/20 0.41
MAPK14 Q16539 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
HIF1A Q16665 1/20 0.40
MAPK9 P45984 1/20 0.40
PDE4A P27815 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
HTT P42858 1/20 0.37
FLT1 P17948 1/20 0.36
KDR P35968 1/20 0.36
FAAH O00519 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
NSD2 O96028 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5233274 0.86 CYP1A2 (0.55) CYP1A2ALDH1A1HPGDLOXL2CYP3A4
SCHEMBL5236988 0.84 CYP1A2 (0.49) CYP1A2ALDH1A1LOXL2CYP3A4CYP2D6
SCHEMBL5235225 0.84 CYP1A2 (0.49) CYP1A2ALDH1A1LOXL2TGFBR1MAPK14
SCHEMBL4872415 0.84 CYP1A2 (0.49) CYP1A2ALDH1A1LOXL2TGFBR1CYP3A4
SCHEMBL29959459 0.84 CYP1A2 (0.49) CYP1A2ALDH1A1LOXL2TGFBR1MAPK14
SCHEMBL5235242 0.83 CYP1A2 (0.46) CYP1A2ALDH1A1LOXL2TGFBR1MAPK14
SCHEMBL29959944 0.82 CYP1A2 (0.47) CYP1A2ALDH1A1HPGDLOXL2TGFBR1
SCHEMBL5234356 0.82 CYP1A2 (0.47) CYP1A2ALDH1A1HPGDLOXL2TGFBR1
SCHEMBL4872056 0.81 CYP1A2 (0.55) CYP1A2ALDH1A1LOXL2MAPK9HTT
SCHEMBL5231886 0.81 MGAM (0.53) CYP1A2ALDH1A1LOXL2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397364-B1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS LILLY CO ELI (US) 2007-07-25 EP disclosed
WO-2004026302-A1 METHODS OF INHIBITING TGF BETA WITH SUBSTITUTED PYRAZOLES ELI LILLY AND COMPANY (US) 2004-04-01 WO disclosed